DXR Q4 2024 Earnings — Daxor Corporation Revenue & Financial Results | Market Cap Arena

DXRDaxor Corporation

$58M

Q4 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$695,307+743.3% YoY

Gross Profit

$620,66389.3% margin

Operating Income

$2M317.2% margin

Net Income

$2M311.7% margin

EPS (Diluted)

$0.44

Cash Flow

Operating Cash Flow

-$502,047

Free Cash Flow

-$502,050

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$37M

Total Liabilities

$840,296

Stockholders' Equity

$36M

Cash & Equivalents

$0

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$695,307	$82,448	+743.3%
Gross Profit	$620,663	$82,448	+652.8%
Operating Income	$2M	$3M	-28.0%
Net Income	$2M	$3M	-34.7%